HDAC9 and Miyoshi myopathy: Drugs currently used for clinical treatment of MM include proteasome inhibitors (bortezomib and carfilzomib), immunomodulatory drugs (pomalidomid), steroid drugs (dexamethasone), chemotherapy drugs (cyclophosphamid), and HDAC inhibitors (panobinostat) (Bird and Boyd, 2019).